This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
INJEX Pharma AG
INJEX Pharma AG, headquartered in Germany, is a pioneering company in the pharmaceutical and medical device industry, specialising in innovative drug delivery systems. Founded in 2006, INJEX has made significant strides in developing needle-free injection technology, which enhances patient comfort and compliance. The company’s flagship product, the INJEX 30, offers a unique solution for administering medications without needles, making it particularly appealing in the fields of diabetes management and vaccinations. With a strong presence in Europe and expanding operations globally, INJEX Pharma AG is recognised for its commitment to quality and innovation, positioning itself as a leader in the needle-free injection market. Notable achievements include various partnerships and collaborations aimed at advancing healthcare solutions, solidifying its reputation as a forward-thinking entity in the pharmaceutical landscape.
DitchCarbon Score
How does INJEX Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Land Transportation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
INJEX Pharma AG's score of 5 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
INJEX Pharma AG's reported carbon emissions
INJEX Pharma AG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. Despite the lack of reported emissions, INJEX Pharma AG's commitment to climate action is evident through its engagement in various sustainability initiatives. However, there are no specific reduction targets or climate pledges documented at this time. As a part of the pharmaceutical industry, INJEX Pharma AG is positioned within a sector that is increasingly focusing on reducing carbon footprints and enhancing sustainability practices. The absence of emissions data highlights an opportunity for the company to establish measurable climate commitments and contribute to broader industry goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
INJEX Pharma AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
